(4Z)-4-[(2S)-2-hydroxy-2-[(4R)-4-nitro-3-[[(2S)-oxan-2-yl]methyl]hex-5-en-2-yl]oxyethylidene]-7-methyl-2,3,4a,5,7,7a-hexahydro-1H-thieno[3,4-b]pyridin-2-ol

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并吡啶类
• 英文名称: (4Z)-4-[(2S)-2-hydroxy-2-[(4R)-4-nitro-3-[[(2S)-oxan-2-yl]methyl]hex-5-en-2-yl]oxyethylidene]-7-methyl-2,3,4a,5,7,7a-hexahydro-1H-thieno[3,4-b]pyridin-2-ol
• 化学式: C22H36N2O6S
• 分子量: 456.6
• InChiKey: KNXGGFHWZRFBMD-XSQNOTRHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  31
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  142
• 氢给体数：
  3
• 氢受体数：
  8

文献信息

• Optical Sorting Method
  申请人：Griffiths Andrew

  公开号：US20140187762A1

  公开（公告）日：2014-07-03

  The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: (a) compartmentalising genetic elements into microcapsules; (b) expressing the genetic elements to produce their respective gene products within the microcapsules; (c) sorting the genetic elements which produce the gene product having the desired activity using a change in the optical properties of the genetic elements. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative applications of the method of the invention.